BioSpace News Archive

Business

SimplePractice Announces Partnership with Illinois Speech-Language Hearing Association (ISHA)

Innovative platform seeks to further empower the work of speech-language pathologists

September 18, 2019
·
2 min read
Genetown

Coalition to Keep Behavioral Health Care Local to Rally on September 23 in Holyoke Against Baystate Health Plan to Close Beds in Greenfield, Palmer and Westfield

A coalition of nurses, mental health professionals, patients, families, elected officials and other community members who are fighting to preserve local inpatient behavioral health services will hold a rally on Monday, Sept. 23 in Holyoke to protest Baystate Health’s plan to close all of the mental health beds in Greenfield, Palmer and Westfield.

September 18, 2019
·
3 min read
Pharm Country

Research Continues to Drive Advances Against Cancer

AACR Cancer Progress Report 2019 details 27 new cancer treatments, a record high number of U.S. cancer survivors, and the benefit of increasing federal investments in medical research through the National Institutes of Health and the National Cancer Institute

September 18, 2019
·
6 min read
Policy

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab) in Lupus Nephritis

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to Gazyva® for adults with lupus nephritis.

September 18, 2019
·
12 min read
Deals

Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline

Themis well-funded through completion of Chikungunya Phase 3 program

September 18, 2019
·
4 min read
BioMidwest

Katalyst Technologies Heats Up the Kitchen to Support Families Fighting Cancer

This summer, team members from Katalyst Technologies competed in Culinary Care’s Corporate Cook-Off.

September 18, 2019
·
3 min read
Biotech Beach

Global Genes Report Finds Technology Reshaping the Rare Disease Landscape, but Non-Scientific Challenges Threaten to Impede Progress

Report seeks to foster creative thinking and new approaches to addressing obstacles to patients getting the answers and care they need

September 18, 2019
·
3 min read
Drug Development

Immunic, Inc. Doses First Healthy Volunteer in its Phase 1 Clinical Program of IMU-935, a Potentially Best-in-Class RORgt Inverse Agonist

Immunic, Inc. announced dosing of the first healthy volunteer in the company’s phase 1 clinical program of IMU-935, a highly potent and selective inverse agonist of the transcription factor RORγt, believed to be the main driver for the differentiation of Th17 cells and the expression of cytokines involved in various inflammatory and autoimmune diseases.

September 18, 2019
·
7 min read
Genetown

Ra Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass General

Ra Pharmaceuticals, Inc. announced the selection of zilucoplan as one of the first clinical candidates to be evaluated in a pioneering platform trial for amyotrophic lateral sclerosis (ALS), led by the Sean M. Healey & AMG Center for ALS at Mass General.

September 18, 2019
·
5 min read
Drug Development

Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes

Imeglimin results featured in symposium session with leading diabetes expert Ralph DeFronzo, M.D., discussing preclinical and clinical data supporting safety and efficacy of Imeglimin in various patient populations with type 2 diabetes

September 18, 2019
·
9 min read